Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Perspective Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CATX: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders4842−6
Shares17.2M27.9M+10.6M (+61.6%)
Value$4.26M$17.8M+$13.5M (+317.4%)

New holders (7)

Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CATX in Q1 2023
InstitutionSharesValue% of portfolio
Osterweis Capital Management Inc1,582,100$1.01M0.07%
Charles Schwab Investment Management Inc116,009$74.0K0.00%
ExodusPoint Capital Management, LP48,719$31.0K0.00%
Dynamic Advisor Solutions LLC40,000$25.5K0.00%
Sowell Financial Services LLC30,000$19.0K0.00%
Chilton Capital Management LLC500$3190.00%
BNP Paribas Arbitrage, SA158$1010.00%

Sold out (13)

Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of CATX in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Citadel Advisors LLC305,635$75.5K
Virtu Financial LLC67,004$17.0K
Jane Street Group, LLC49,436$12.2K
HRT Financial LP30,189$7.00K
Bremer Bank National Association29,411$7.00K
Susquehanna International Group, LLP19,354$4.78K
Two Sigma Securities, LLC16,327$4.03K
Victory Capital Management Inc15,959$3.94K
Mendota Financial Group, LLC15,000$3.71K
Millennium Management LLC13,705$3.00K
FMR LLC6,266$1.55K
Bank of America Corp336$82
Arcadia Investment Advisors LLC222$55